These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12480736)

  • 1. Molecular and functional dissection of TGF-beta1-induced cerebrovascular abnormalities in transgenic mice.
    Buckwalter M; Pepper JP; Gaertner RF; Von Euw D; Lacombe P; Wyss-Coray T
    Ann N Y Acad Sci; 2002 Nov; 977():87-95. PubMed ID: 12480736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice.
    Wyss-Coray T; Lin C; Sanan DA; Mucke L; Masliah E
    Am J Pathol; 2000 Jan; 156(1):139-50. PubMed ID: 10623661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease-like cerebrovascular pathology in transforming growth factor-beta 1 transgenic mice and functional metabolic correlates.
    Wyss-Coray T; Lin C; von Euw D; Masliah E; Mucke L; Lacombe P
    Ann N Y Acad Sci; 2000 Apr; 903():317-23. PubMed ID: 10818521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.
    Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L
    Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's disease.
    Ongali B; Nicolakakis N; Lecrux C; Aboulkassim T; Rosa-Neto P; Papadopoulos P; Tong XK; Hamel E
    Am J Pathol; 2010 Dec; 177(6):3071-80. PubMed ID: 21088218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrovascular pathology during the progression of experimental Alzheimer's disease.
    Giannoni P; Arango-Lievano M; Neves ID; Rousset MC; Baranger K; Rivera S; Jeanneteau F; Claeysen S; Marchi N
    Neurobiol Dis; 2016 Apr; 88():107-17. PubMed ID: 26774030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced brain tissue perfusion in TGF-beta 1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities.
    Gaertner RF; Wyss-Coray T; Von Euw D; Lesné S; Vivien D; Lacombe P
    Neurobiol Dis; 2005; 19(1-2):38-46. PubMed ID: 15837559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.
    Wyss-Coray T; Lin C; Yan F; Yu GQ; Rohde M; McConlogue L; Masliah E; Mucke L
    Nat Med; 2001 May; 7(5):612-8. PubMed ID: 11329064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1 affects endothelial cell interaction with macrophages and T cells leading to the development of cerebrovascular amyloidosis.
    Weiss R; Lifshitz V; Frenkel D
    Brain Behav Immun; 2011 Jul; 25(5):1017-24. PubMed ID: 21112386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β1 factor in the cerebrovascular diseases of Alzheimer's disease.
    Zhang X; Huang WJ; Chen WW
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5178-5185. PubMed ID: 28051272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a polymorphism of the transforming growth factor-beta1 gene with cerebral amyloid angiopathy.
    Hamaguchi T; Okino S; Sodeyama N; Itoh Y; Takahashi A; Otomo E; Matsushita M; Mizusawa H; Yamada M
    J Neurol Neurosurg Psychiatry; 2005 May; 76(5):696-9. PubMed ID: 15834029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral circulation: function and dysfunction in Alzheimer's disease.
    Hamel E
    J Cardiovasc Pharmacol; 2015 Apr; 65(4):317-24. PubMed ID: 25384195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein.
    Niwa K; Kazama K; Younkin SG; Carlson GA; Iadecola C
    Neurobiol Dis; 2002 Feb; 9(1):61-8. PubMed ID: 11848685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular remodeling versus amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease.
    Tong XK; Nicolakakis N; Kocharyan A; Hamel E
    J Neurosci; 2005 Nov; 25(48):11165-74. PubMed ID: 16319316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy.
    Saito S; Yamamoto Y; Maki T; Hattori Y; Ito H; Mizuno K; Harada-Shiba M; Kalaria RN; Fukushima M; Takahashi R; Ihara M
    Acta Neuropathol Commun; 2017 Apr; 5(1):26. PubMed ID: 28376923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective in vivo antagonism of endothelin receptors in transforming growth factor-beta1 transgenic mice that mimic the vascular pathology of Alzheimer's disease.
    Papadopoulos P; Ongali B; Hamel E
    Can J Physiol Pharmacol; 2010 Jun; 88(6):652-60. PubMed ID: 20628431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models.
    Burgermeister P; Calhoun ME; Winkler DT; Jucker M
    Ann N Y Acad Sci; 2000 Apr; 903():307-16. PubMed ID: 10818520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan improves cerebrovascular function in a mouse model of Alzheimer's disease with combined overproduction of amyloid-β and transforming growth factor-β1.
    Papadopoulos P; Tong XK; Imboden H; Hamel E
    J Cereb Blood Flow Metab; 2017 Jun; 37(6):1959-1970. PubMed ID: 27389178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound cerebrolysin.
    Rockenstein E; Adame A; Mante M; Larrea G; Crews L; Windisch M; Moessler H; Masliah E
    J Neural Transm (Vienna); 2005 Feb; 112(2):269-82. PubMed ID: 15657642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta 1 impairs endothelin-1-mediated contraction of brain vessels by inducing mitogen-activated protein (MAP) kinase phosphatase-1 and inhibiting p38 MAP kinase.
    Tong XK; Hamel E
    Mol Pharmacol; 2007 Dec; 72(6):1476-83. PubMed ID: 17848599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.